All In Biotech

Drug Trial Radar · NCT03384979

Optimization of Contrast Agent Dose in CT With Lean Body Weight

Randomized Controlled Trial of Optimization of Contrast Agent Dose in CT With Lean Body Weight

Last checked: Nov 19, 2026Latest source record: May 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 274 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

274

Actual

Start

Dec 18, 2017

Primary completion

Feb 25, 2019

Study completion Feb 25, 2019

Sponsor

Lead sponsor
IRCCS Policlinico S. DonatoAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 28, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Supportive care
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the different enhancement using a contrast agent dose in computed tomography based on total body weight or based on lean body weight. Half of participants will receive contrast agent dose based on their total body weight, while the other half will receive a dose based on their lean body weight. Our hypothesis is that if contrast agent is administered not basing on total body weight but on lean body weight it is possible to obtain equal or better quality of enhanced images, a reduction of the variability of contrast enhancement, and also a dose reduction in some patients (overweight ones).

Conditions

  • Contrast Agent With Lean Body Weight

Interventions

  • IopamidolDrug

    Contrast agent will be adrministered intravenously using total body weight or lean body weight, calculated with bioelectrical impedance analysis balance.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Contrast EnhancementTime frame: 1 day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • IRCCS Policlinico San Donato

    San Donato Milanese, Milan, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.